- Home
- MHH vs SLRX Comparison
MHH vs SLRX Comparison
Compare MHH & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- SLRX
- Stock Information
- Founded
- MHH 1986
- SLRX N/A
- Country
- MHH United States
- SLRX United States
- Employees
- MHH N/A
- SLRX N/A
- Industry
- MHH Professional Services
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MHH Consumer Discretionary
- SLRX Health Care
- Exchange
- MHH Nasdaq
- SLRX Nasdaq
- Market Cap
- MHH 86.6M
- SLRX 2.9M
- IPO Year
- MHH N/A
- SLRX N/A
- Fundamental
- Price
- MHH $7.58
- SLRX $5.56
- Analyst Decision
- MHH
- SLRX
- Analyst Count
- MHH 0
- SLRX 0
- Target Price
- MHH N/A
- SLRX N/A
- AVG Volume (30 Days)
- MHH 10.8K
- SLRX 286.4K
- Earning Date
- MHH 11-05-2025
- SLRX 11-13-2025
- Dividend Yield
- MHH N/A
- SLRX N/A
- EPS Growth
- MHH N/A
- SLRX N/A
- EPS
- MHH 0.07
- SLRX N/A
- Revenue
- MHH $200,000,000.00
- SLRX N/A
- Revenue This Year
- MHH N/A
- SLRX N/A
- Revenue Next Year
- MHH $3.78
- SLRX N/A
- P/E Ratio
- MHH $101.33
- SLRX N/A
- Revenue Growth
- MHH 5.16
- SLRX N/A
- 52 Week Low
- MHH $6.20
- SLRX $4.50
- 52 Week High
- MHH $16.00
- SLRX $108.00
- Technical
- Relative Strength Index (RSI)
- MHH 48.65
- SLRX 43.47
- Support Level
- MHH $7.36
- SLRX $4.79
- Resistance Level
- MHH $7.90
- SLRX $5.90
- Average True Range (ATR)
- MHH 0.36
- SLRX 0.40
- MACD
- MHH -0.03
- SLRX 0.27
- Stochastic Oscillator
- MHH 36.73
- SLRX 75.36
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.